Inspire Medical Systems, Inc.
NYSE:INSPMedical - Devices
+$0.51 today
- Market cap
- $1.68B
- Beta
- 0.73
- P/E (TTM)
- 9.1
- EPS (TTM)
- $4.57
Volume 0.51M
Average 1.13M
INSP Inventory
Raw materials, work in progress, and finished goods held for sale.
Inspire Medical Systems, Inc.NYSE: INSP
Inventory · Q2 FY2026 · quarter ended Jun 2026
Inventory rises 40.1% from a year ago
Inventory stood at $170.45M at the end of Q2 FY2026, up 40.1% from a year earlier and up 2.5% from the prior quarter. Over 3 fiscal years it compounded at +130.4% a year.
Context
- Inventory amounted to 18.4% of total assets at the end of Q2 FY2026, up 3.2 pp from a year earlier.
- Inventory increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether inventory keeps rising in the next quarterly balance sheet after a +40.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Inventory history
USD · from the balance sheet
- Latest · FY2025
- 145.29M USD
- Year-over-year change
- +81.3%
- 4-year CAGR
- +70.4%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 145.29M | +81.3% |
| FY2024 | 2024-12-31 | 80.12M | +136.4% |
| FY2023 | 2023-12-31 | 33.89M | +185.1% |
| FY2022 | 2022-12-31 | 11.89M | -31.0% |
| FY2021 | 2021-12-31 | 17.23M | — |
Inventory vs competitors
How INSP compares with its peers on the latest reported figures
- INSP's Jun 2026 inventory of $170.45M is the 2nd highest of the 9 companies compared; the peer median is $74.18M.
- Its year-over-year change of +40.1% is the highest of 6, against a peer median of +19.6%.
- Inventory amounts to 18.4% of total assets for INSP, versus a peer median of 5.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $288.06M | +8.1% | +6.7% | 8.4% | |
| Jun 2026 | $170.45M | +40.1% | +130.4% | 18.4% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $119.84M | -0.4% | +3.4% | 2.3% |
| Mar 2026 | $98M | +19.6% | +7.5% | 11.1% | |
| Mar 2026 | $77.54M | +24.4% | +35.3% | 15.9% | |
| Mar 2026 | $70.82M | +26.5% | +15.9% | 11.2% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding INSP) | $74.18M | +19.6% | +7.5% | 5.3% | |
Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 214.47M | 441.59M | 185.54M | 150.15M | 104.81M |
| Short-term Investments | 0 | 9.82M | 274.84M | 295.4M | 203.46M |
| Net Receivables | 34.18M | 61.23M | 89.88M | 93.07M | 119.69M |
| Inventory | 17.23M | 11.89M | 33.89M | 80.12M | 145.29M |
| Other Current Assets | 0 | 5.51M | 9.6M | 12.07M | 10.4M |
| Total Current Assets | 268.54M | 530.03M | 593.74M | 630.81M | 583.65M |
| Property, Plant & Equipment (Net) | 16.41M | 24.13M | 62.65M | 95.24M | 121.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 9.94M | 10.5M | 9.14M | 71M | 96.33M |
| Tax Assets | 0 | 0 | 0 | 0 | 88.67M |
| Other Non-current Assets | 204K | 215K | 11.28M | 11.34M | 17.26M |
| Total Non-current Assets | 26.55M | 34.84M | 83.07M | 177.58M | 323.66M |
| Total Assets | 295.08M | 564.88M | 676.81M | 808.38M | 907.32M |
| Account Payables | 11.67M | 26.85M | 38.84M | 38.69M | 36.57M |
| Short-term Debt | 9.19M | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 577K | 1.61M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 8.41M |
| Total Current Liabilities | 41.31M | 61.19M | 78.11M | 88.5M | 96.06M |
| Long-term Debt | 15.8M | 7.54M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 134K | (7.39M) | 1.35M | 148K | 104K |
| Total Non-current Liabilities | 24.73M | 7.68M | 26.19M | 30.19M | 30.1M |
| Total Liabilities | 66.04M | 68.87M | 104.3M | 118.69M | 126.16M |
| Common Stock | 27K | 29K | 30K | 30K | 29K |
| Retained Earnings | (279.39M) | (324.27M) | (345.42M) | (291.91M) | (146.49M) |
| Accumulated OCI | (55K) | (86K) | 800K | 536K | 464K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 229.05M | 496.01M | 572.51M | 689.7M | 781.16M |
| Total Debt | 34.1M | 16.41M | 24.85M | 31.79M | 32.16M |
| Net Debt | (180.37M) | (425.18M) | (160.69M) | (118.36M) | (72.66M) |
Inspire Medical Systems, Inc.
NYSE:INSP
Intrinsic Alpha fair value
Locked
Current Price
$58.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.